New York, NY – June 4, 2019 – SK Capital Partners, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, today announced it is bolstering its focus on the lower middle market through the addition of several new investment professionals, including Jonathan Borell (Managing Director), Shawn Abrams (Operating Director), Dan Lory (Vice President), and Blake Shapskinsky (Associate).
Led by SK Managing Director Mario Toukan in partnership with Jonathan Borell, this newly assembled team will pursue the same sector-focused, operationally-intensive investment strategy that SK Capital is currently executing and will bring the global resources and deep industry expertise of SK Capital to lower middle market businesses.
“The lower middle market represents a large universe of opportunities for transformational investing and should enable us to capitalize on the firm’s presence in our focused sectors,” said Barry Siadat, a co-founder and Managing Director of SK Capital.
Jonathan Borell – Managing Director. Mr. Borell was most recently a Managing Director at Sun Capital Partners, where he spent 13 years leading investment sourcing and execution across a variety of industries, including chemicals and healthcare. Prior to Sun Capital, Mr. Borell was with Raymond James & Associates and is a graduate of Duke University.
Shawn Abrams – Operating Director. Mr. Abrams has more than 30 years of experience in the global chemicals and materials industries. He was most recently an Operating Partner at Arsenal Capital Partners where he spent 3 years managing several portfolio companies. Prior to Arsenal, Mr. Abrams served as a senior executive at WR Grace and Evonik Industries. Mr. Abrams is a graduate of Lehigh University with an MBA from Thunderbird School of Management.
Dan Lory – Vice President. Mr. Lory was most recently a Vice President at KeyBanc Capital Markets, where he spent 8 years in the chemicals and materials practice. Prior to KeyBanc, Mr. Lory started his career with FTI Consulting and is a graduate of the University of Notre Dame.
Blake Shapskinsky – Associate. Mr. Shapskinsky was most recently an Associate at Tailwind Capital Partners, where he spent two years evaluating new opportunities and managing investments in the healthcare, business services, and industrial services sectors. Prior to Tailwind Capital, Mr. Shapskinsky was an analyst in the chemicals group at Deutsche Bank and is a graduate of Middlebury College.
“These new investment professionals, who will be based in SK Capital’s New York office, represent outstanding talent with an extensive history of working together over the past decade and over 75 years of sector experience and relationships,” said Mario Toukan.
ABOUT SK CAPITAL
SK Capital is a private investment firm with a disciplined focus on the specialty materials, chemicals and pharmaceuticals sectors. The firm seeks to build strong and growing businesses that create substantial long-term value. SK Capital utilizes its industry, operating and investment experience to identify opportunities to transform businesses into higher performing organizations with improved strategic positioning, growth and profitability as well as lower operating risk. For more information, please visit www.skcapitalpartners.com.